ArticlePharmaceutics2021

Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization.

E Seul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.